Indian J Anim Reprod 42(1):6164 Lanzolla G, Marin M, Menconi F (2024) Graves disease: latest understanding of pathogenesis and treatment options
Areas of Interest Laboratory studies of Retatrutide have investigated a variety of promising areas: Energy homeostasis & metabolic flexibility studied for its effects on energy expenditure, substrate utilisation, and metabolic adaptation in preclinical models
Future research Further research is required to determine the optimal duration of semaglutide and other GLP-1 agonist therapies and to identify effective strategies for maintaining and discontinuing the weight-reducing GLP-1 agonist treatment
It is recommended for those with saggy skin, dull skin, uneven skin surface, no glow, pimples, skin discolouration, pigmentation, scars, acne scars, dark skin and eczema
One notable study reported that participants who took semaglutide experienced an average weight loss of 14.9% from their baseline weight over a 68-week period, compared to 2.4% in the placebo group